Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

You may also be interested in...



Criminal Charges Against Hoodia Suppliers, Consent Decree For Herpes Claim Firm

Diverting PSE for meth among four criminal charges against N.J. firms also marketing adulterated hoodia; and complaint on Florida firm's STD claims comes four years after warning about possible prosecutions.

Senate Committee Restores FDA Funding For FY ’12

The Senate Appropriations Committee gives FDA a boost for fiscal 2012 that likely will stick, thanks to the recent debt ceiling compromise.

In Brief

Chaffetz will not challenge Hatch

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105399

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel